Examples of using Genentech in Chinese and their translations into English
{-}
-
Political
-
Ecclesiastic
-
Programming
后来罗氏终于在2008年以470亿美元收购了Genentech的少数股东。
Roche finally bought out minority investors in Genentech 牵头的是GoogleVentures的创始合伙人BillMaris，他聘请了Genentech前CEOArtLevinson担任首席执行官。
Led by Bill Maris, founding partner 例如，生物技术企业Genentech公司将“谷歌应用”服务用于电子邮件，以及用于创建文档和电子表格，从而省去了对服务器和软件使用许可权的资本投资。
The biotechnology company Genentech, for example, uses Google Apps for e-mail and to create documents and spreadsheets, bypassing capital investments in servers and software licenses.罗氏/Genentech.
Roche/ Genentech.ALIGN-2程序可以从Genentech，Inc.
The ALIGN-2 program is publicly available from Genentech, Inc.Genentech开辟了全球生物技术产业。
For example, Genentech created the biotech industry.ALIGN-2序列比较计算机程序由Genentech，Inc.
Computer program ALIGN-2, is used to compare the sequences was developed by Genentech, Inc.该研究由F.Hoffmann-LaRoche和Genentech资助。
The study was supported by F. Hoffmann- La Roche/Genentech.注意：IPPF不隶属于Access解决方案或Genentech。
Note: The IPPF is not affiliated with Access Solutions or Genentech.该研究由F.Hoffmann-LaRoche和Genentech资助。
This study was supported by F. Hoffmann La Roche/Genentech.Genentech于2009年被Roche药厂以468亿美元收购。
Genentech was acquired by Roche for $46.8 billion in 2009.该研究由F.Hoffmann-LaRoche和Genentech资助。
The study was funded by F. Hoffmann- La Roche/Genentech.Calico由前Genentech首席执行官ArthurLevinson经营。
Calico is led by Arthur Levinson, the former CEO of Genentech.该研究由F.Hoffmann-LaRoche和Genentech资助。
The study was funded by F. Hoffmann-La Roche/Genentech Inc.Calico由前Genentech首席执行官ArthurLevinson经营。
The company is run by former Genentech CEO Arthur Levinson.罗氏/Genentech支持NCI合作研发协议，支持该试验。
Roche/Genentech supported the NCI cooperative research and development agreement enabling this trial.谷歌、Genentech、NEA和强生都是它的投资人。
Google, Genentech, NEA and Johnson& Johnson are amongst its prior investors.Genentech在2009年3月被Roche(罗氏)收购。
Genentech was acquired in March 2009 by Roche Holding AG.Genentech在2017开始一个新的3期试验gantenerumab。
Genentech started a new phase 3 trial for gantenerumab in 2017.Calico由前Genentech首席执行官ArthurLevinson经营。
Calico is led by Arthur Levinson, the former CEO of Genentech.
